Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1

Conditions

Breast Neoplasms 276Carcinoma, Non-Small-Cell Lung 243Neoplasms 227Prostatic Neoplasms 185Colorectal Neoplasms 175Multiple Myeloma 135Lung Neoplasms 132Ovarian Neoplasms 118Neoplasm Metastasis 118Leukemia, Myeloid, Acute 107Pancreatic Neoplasms 102Melanoma 90Squamous Cell Carcinoma of Head and Neck 87Recurrence 78Endometrial Neoplasms 75Carcinoma, Renal Cell 71Lymphoma, Non-Hodgkin 70Precursor Cell Lymphoblastic Leukemia-Lymphoma 67Lymphoma 66Stomach Neoplasms 64Glioblastoma 63Carcinoma, Hepatocellular 63Brain Neoplasms 62Glioma 60Sarcoma 57Head and Neck Neoplasms 57Uterine Cervical Neoplasms 56Triple Negative Breast Neoplasms 55Leukemia, Lymphocytic, Chronic, B-Cell 54Urinary Bladder Neoplasms 50

Interventions

selinexor 1pazopanib 1Proton Therapy 1Ifosfamide 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasms, Adipose Tissue × 30 days × Clear all
NCT06239272 2026-05-19

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
139 enrolled
Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Glomus Tumor, Granuloma, Plasma Cell, Hemangiosarcoma, Liposarcoma, Myoepithelioma, Sarcoma, Osteosarcoma, Disorders of Sex Development, Granular Cell Tumor, Neoplasms, Adipose Tissue, Liposarcoma, Myxoid, Dermatofibrosarcoma, Sarcoma, Clear Cell, Smooth Muscle Tumor, Nerve Sheath Neoplasms, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Vascular Neoplasms, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡